Martha Gulati/www.womenheart.org; Annalisa Filtz, Leandro Slipczuk/LinkedIn
Mar 21, 2026, 11:34
Martha Gulati: How Does Lp(a) Drive Atherosclerosis?
Martha Gulati, Director of the Davis Women Heart Center at Houston Methodist DeBakey Heart and Vascular Center, shared a post on LinkedIn about a recent article she and her colleagues co-authored, adding:
“How does Lp(a) drive atherosclerosis?
- Delivers cholesterol to the arterial wall
- Carries oxidized phospholipids, leading to vascular inflammation
- Interferes with plasminogen, resulting in impaired fibrinolysis
- Promotes an atherothrombotic environment
Understanding these mechanisms strengthens the case for targeted Lp(a) therapies.”
Title: Presumed Mechanisms Underlying Lipoprotein(a)-caused Atherosclerosis
Authors: Annalisa Filtz, Leandro Slipczuk, Martha Gulati
Read the Full Article on ECR Journal.
Stay updated on all scientific advances with Hemostasis Today.
-
Oct 9, 2026, 16:23David Boone: Distinguishing Stroke Prevention from Rhythm Control in Atrial Fibrillation
-
Oct 9, 2026, 15:27Mohamed Hegazi: Geostatistical Modelling Maps Global β-Thalassaemia Carrier Prevalence
-
Oct 9, 2026, 15:15Maha Othman: Uncovering the Consensus on TXA in TBI – Call for Collaboration on a Landmark Umbrella Review
-
Oct 9, 2026, 15:07Daniel D. Han: How Inhalation Product Exposure Impairs Cardiac and Platelet Recovery After MI
-
Oct 9, 2026, 14:58William Toole: How Ultrasound-Guided PRP Therapy Relieves Joint and Tendon Pain
-
Oct 9, 2026, 14:50Shayan Mohammadmoradi: In Corpus Christi for the 20th Midwest Platelet Conference
-
Oct 9, 2026, 14:37Tariq Tramboo: High Platelet Concentrate for Osteoarthritis Knee – Recent Meta-Analyses
-
Oct 9, 2026, 14:26Yousma Khan: Hematology Series – Beyond RBCs, WBCs and Platelets
-
Oct 9, 2026, 14:13Jesus Ardila Novoa: Why the WHO’s Historic Essential Medicines List Decision Is Just the Beginning